Andro Bill Driven By National Media Coverage, Biden Says
This article was originally published in The Tan Sheet
Executive Summary
Attention from ESPN and other national media has been a primary impetus behind growing support for legislation that would make androstenedione and other steroid precursors controlled substances
You may also be interested in...
Andro Targeted By FDA In Coordination With Capitol Hill Action
FDA is aiming to remove androstenedione supplements from the market by classifying the substance as a new dietary ingredient that has not been the subject of a safety notification to the agency, as required by the Dietary Supplement Health & Education Act
Ephedra Supplement Restriction Appropriate Under DSHEA? -Hatch to Henney
FDA Commissioner-nominee Jane Henney, MD, is asked to provide her views on the agency's use of adverse events data on ephedra-containing dietary supplements as a primary basis for proposed restrictions on such products in an Oct. 1 letter from Sen. Orrin Hatch (R-Utah).
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC